Transcription of INDICATIONS AND USAGE - azpicentral.com
{{id}} {{{paragraph}}}
Example: confidence
INDICATIONS AND USAGE - azpicentral.com
HIGHLIGHTS OF PRESCRIBING INFORMATIONT hese highlights do not include all the information needed to use FARXIGA safely and effectively. See full prescribing information for (dapagliflozin) tablets, for oral useInitial Approval: 2014-----------------------------INDICAT IONS AND USAGE -----------------------------FARXIG A is a sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1)Limitation of use: Not for treatment of type 1 diabetes mellitus or diabetic ketoacidosis. ( )---------------------------DOSAGE AND ADMINISTRATION------------------------- The recommended starting dose is 5 mg once daily, taken in the morning, with or without food. ( ) Dose can be increased to 10 mg once daily in patients tolerating FARXIGA who require additional glycemic control.
ization have been identified in postmarketing surveillance in patients with type 1 and type 2 diabetes mellitus receiving sodium-glucose cotransporter 2 (SGLT2) inhibitors,
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Acute, In patients, Drug, Patients, KDIGO Clinical Guidelines for Management of, Kidney, Drug-induced peptic ulcer disease, N-acetylcysteine) Hydration Oral NAC dosing, N-acetylcysteine) + Hydration Oral NAC dosing, Radiology Reimbursement Information Setting:, Radiology Reimbursement Information Setting: Hospital Outpatient